The micro-randomized trial (MRT) is a new experimental design which allows for the investigation of the proximal effects of a "just-in-time" treatment, often provided via a mobile device as part of a mobile health intervention. As with a traditional randomized controlled trial, computing the minimum required sample size to achieve a desired power is a crucial step in designing an MRT. We present MRT-SS Calculator, an online sample-size calculator for micro-randomized trials, built with R Shiny. MRT-SS Calculator requires specification of time-varying patterns for the proximal treatment effect and expected treatment availability. We illustrate the implementation of MRT-SS Calculator using a mobile health trial, HeartSteps. The application can be accessed from https://pengliao.shinyapps.io/mrt-calculator.
Introduction
Due to recent advances in mobile technologies, including smartphones and sophisticated wearable sensors, mobile health (mHealth) technologies are drawing much attention in the behavioral health community. In "just-in-time" mobile interventions, treatments, provided via a mobile or wearable device, are intended to help an individual in the moment. For example, treatments might promote engaging in a healthy behavior when an opportunity arises, or successfully coping with a stressful event. A challenge in developing just-in-time mobile interventions is the limited experimental methodology available to support their development. Current experimental designs do not readily enable researchers to empirically investigate whether a just-in-time treatment had the intended effect, or when and in which context it is useful to deliver a treatment.
Recently, a new experimental design, called the micro-randomized trial (MRT), has been developed to assess the effects of these interventions (Liao et al., 2016) . In these trials, participants are sequentially randomized between intervention options at each of many occasions (decision times) at which treatment might be provided. As with traditional randomized controlled trials, determining sample size is an important part of the process of designing a 1 arXiv:1609.00695v2 [stat.ME] 10 Sep 2016 micro-randomized trial. More specifically, it is important for the scientist to justify the number of participants or experimental units needed in the study to address a specific scientific question with a given power (Noordzij et al., 2010) .
Here, we introduce MRT-SS Calculator, a user-friendly, web-based application designed to facilitate determination of the minimal sample size needed to detect a given effect of a just-in-time intervention. The application was built using R Shiny (R Core Team, 2016; Chang et al., 2016) . Commonly, tools used to compute sample sizes can be difficult to use, particularly for non-statisticians. MRT-SS Calculator provides a clean, intuitive user interface which elicits study parameters from the scientist in a thoughtful way, while still offering enough flexibility to accommodate more complex trials. The calculator is based on methodology reviewed in Section 2. In Section 3, we provide a detailed tour of MRT-SS Calculator and describe its use. Finally, in Section 4, we introduce HeartSteps, a microrandomized trial investigating the use of mobile interventions to increase physical activity in sedentary adults. With HeartSteps as an example, we illustrate the use of MRT-SS Calculator in a "real-world" setting.
Review of methodology used in MRT-SS Calculator
MRT-SS Calculator implements the methodology developed in Liao et al. (2016) . Here, we present a brief review. A micro-randomized trial provides participants with randomlyassigned treatments at each of T decision times, indexed by t ∈ [T ]. Depending on the study, the number of decision times T may be in the 100's or 1000's; in the HeartSteps example described in Section 4, T = 210. A simplified version of the longitudinal data collected from each participant in an MRT can be written as
where S 0 is a vector of the individual's baseline information (e.g., age, gender). This calculator is developed for binary treatment, A t ∈ {0, 1}; that is, there are two intervention options at decision time t. The proximal response to treatment A t is denoted by Y t+1 . I t is an indicator for the participant's "availability" at time t. At some decision times, the participant may be unavailable for treatment; that is, it may be unethical, scientifically inappropriate, or infeasible to deliver a treatment. For example, if treatment involves delivering messages via audible and visual cues on a smartphone, it would be considered unethical to deliver these potentially distracting messages while the participant is driving a car. In such situations, the participant is classified as unavailable, and I t = 0. During time periods when I t = 0, participants are not randomized and A t is left undefined.
At decision time t, the proximal effect of a treatment, denoted β(t), is defined as translates the index of each treatment occasion to an index of the number of days that have elapsed since the outset of the study. In Section 3.3, we consider other treatment effect trends.
We construct a test statistic based on the least-squares estimate of β from the following working model for E[Y t+1 |I t = 1, A t ]:
where B t is a q × 1 vector function of t and covariates that are unaffected by treatment, such as gender, time of day, and day of the week, and ρ t = P [A t = 1] is the randomization probability at decision time t. The associated test statistic is given by Nβ Σ −1 ββ whereβ is the least-squares estimator that minimizes
where P N is the average over the sample with size N , andΣ β is an estimator of the asymptotic variance of √ Nβ (Liao et al., 2016) . The rejection region for the test is
where F p,N −q−p is the F distribution with d 1 = p and d 2 = N −q−p. To derive a tractable sample size formula, Liao et al. (2016) make additional working assumptions. Under these assumptions, the minimum-required sample size N to detect the alternative with power 1−β 0 is found by solving
where F p,N −q−p;c N is the p th quantile of the non-central F distribution with non-centrality parameter
where d is a p-dimensional vector of standardized effects; see the definition in Liao et al. (2016) .
Using MRT-SS Calculator
In this section, we will explain how to use MRT-SS Calculator. In brief, the user should provide basic information about the study as well as the alternative hypothesis and expected availability of participants over the course of the trial. MRT-SS Calculator will return either the minimum required sample size to achieve a specified power, or the power achievable given a specified number of participants. We explore each of these components in detail below.
Study setup
Scientists using MRT-SS Calculator are first prompted to provide specific details describing their planned trial. These include the study's duration in days, the daily number of decision times at which treatment is randomly assigned, and the probability of being randomized to receive treatment.
For example, Figure 1 describes a study which takes place over 42 days with up to 5 randomizations per day, where treatment is delivered with probability 0.4 at each decision time (A t = 1 if treatment is delivered, A t = 0 if no treatment). Using the notation established in Section 2, T = 42 × 5 = 210, and ρ t = P [A t = 1] = 0.4 for all t ∈ [T ]. Given this randomization probability, participants in the study will be delivered an average two treatments per day, provided they are available. Treatments are not provided when the participant is unavailable (and thus the participant is not randomized), for the reasons described above.
Some users may wish to vary the randomization probability over the course of the study. MRT-SS Calculator is flexible enough to accommodate this. The user can upload a .csv file containing randomization probabilities for each day of the study, or for every individual decision time point (see Figure 2 ). Figure 2: Time-varying randomization probabilities. The user specifies whether to provide probabilities which change either daily or at each decision time, and uploads a .csv file containing (index, probability) pairs. A template file is provided for ease of use, and a preview of the uploaded file is shown for verification. many factors, including, for example, whether the participant has turned off the intervention. MRT-SS Calculator provides three classes of trends for expected availability: constant, linear, and quadratic (see Figure 3 ). These trends are averaged over each day, i.e., if there are multiple decision times per day then the trend is in the average over the multiple decision times.
The different classes of expected availability patterns correspond to a variety of scenarios. For example, if it is believed that participants will be more likely to turn off the intervention as the study goes on, then expected availability will decrease. This might occur if, for example, participants find the interventions more burdensome as the study goes on.
MRT-SS Calculator requires the user to provide inputs which fully specify the pattern of expected availability over the course of the study. For example, after selecting the quadratic class of trends, the user is prompted to provide an estimate of participants' average availability throughout the study, the estimated availability for participants at the outset of the trial, and the day of maximum or minimum availability (the "changing point"). See Figure 4 for examples of how different values of these inputs change the pattern of expected availability.
Specifying the targeted alternative effect
MRT-SS Calculator requires the user to specify the desired detectable standardized treatment effect d. Recall from Section 2 that the targeted alternative effect is of the form β(t) = Z t β, where Z t is some function of time. Here d is a standardized β; see Liao et al. (2016) . MRT-SS Calculator allows the user to choose the form of Z t from constant, linear, or quadratic classes of trends (see Figure 5 ). In all classes the trends are averaged over each day, as with the pattern of expected availability (see Section 3.2).
Each of these classes corresponds to a different possible targeted alternative. A constant trend is most useful if the user believes that the effect of the treatment will be relatively stable over the duration of the study. A linear trend is useful if, for example, users believe that the effect of the treatment may grow over time and is unlikely to dissipate at later decision times. A quadratic trend would be useful if it is believed that the treatment effect will grow initially but may dissipate with time as participants begin to ignore or disengage from treatment.
Output
MRT-SS Calculator allows the user to choose to compute either the minimum sample size required to achieve a specified power or the achievable power given a specified sample size. In both cases, the significance level of the test must be supplied. Figure 6 shows the use of MRT-SS Calculator to obtain a minimum sample size for a 42-day study with 5 decision times per day. All computed results from a session are saved, and users can view and/or download all past output from their current session.
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(a) Specification of a constant availability pattern over the course of the trial.
(b) Specification of a linearly-increasing availability pattern over the course of the trial. A linearlydecreasing pattern can be specified by adjusting the initial value and average.
(c) Specification of a quadratic pattern of availability. In the pictured trend, availability decreases over the course of the trial. "Changing point" refers to the day on trial at which expected availability is a maximum or minimum. , and quadratic (c). Included in the plots are the null hypothesis (β(t) = 0 for all t) in blue, the specified average treatment effect in black, and the alternative β(t) = Z t β in red.
(a) Selection of calculator output. To determine minimum-required sample size for a trial, the user inputs the desired power to detect the targeted alternative proximal treatment effect, and the significance level for the planned hypothesis test. Error handling for inputs which lead to negative proximal treatment effects. In a 42-day study, choosing "Day of Maximal Proximal Effect" less than 22 when using the quadratic class with an initial effect of zero will result in a negative value of proximal treatment effect on some days. The application will produce an error message.
Error handling
The MRT-SS Calculator delivers warnings when inappropriate inputs are provided. For example, the warning provided in Figure 7 will appear if the entered "Day of Maximal Proximal Effect" is less than 22 in 42-day study when the initial effect is set to be 0. This is because some values of the resulting treatment effect are less than 0, which should be avoided. When the calculated sample size is less than 10, MRT-SS Calculator will return 10 with a warning. In Appendix A, we conduct a simulation study to investigate different scenarios in which the required sample size is less than 10, or equivalently the estimated power for a sample size of 10 is larger than the desired power. In particular, we compare the power estimated by MRT-SS Calculator with the simulated power under different generative models. In general, the power performance under a variety of generative models when sample size is equal to 10 is slightly degenerated compared to scenarios with relatively large sample sizes.
An example: HeartSteps

Introduction to HeartSteps
HeartSteps is a mobile intervention study designed to increase physical activity for sedentary adults (Klasnja et al., 2015) . HeartSteps uses a mobile application to investigate the effects of in-the-moment activity suggestions. These are messages which encourage the participant to engage in physical activity and which appear on the lock screen of the participant's mobile phone. The suggestions may vary in content depending on a number of contextual factors such as weather, the participant's location, or the time of day. Participants are randomized to either receive or not receive a suggestion at five pre-specified decision times throughout the day. These time points correspond roughly to a morning commute, mid-day, mid-afternoon, an evening commute, and after dinner. When a suggestion is delivered, it is displayed on the lock screen of the phone, which then plays a notification sound, vibrates, or lights up.
In HeartSteps, data are collected both passively via sensors and actively through participant self-report. Each participant is provided a Jawbone UP activity tracker which monitors and records step count. Furthermore, sensors on the phone are used to collect a variety of information at each of the five decision times during the day. This information includes the participant's current location and activity status (e.g., walking, driving, etc.). If sensors indicate that the individual is likely walking or driving a car, activity suggestions are not delivered (the availability indicator I t is set to 0).
Illustration of MRT-SS Calculator with HeartSteps
HeartSteps is a 42-day trial with five decision times per day, so that T = 210. Suppose we wish to size the trial to detect a given proximal effect of the intervention on a participant's step count. Notice that this is a binary treatment: participants are randomized to be delivered a suggestion or not. Suggestions are delivered with constant probability ρ = P [A t = 1] = 0.4 over the course of the study, so that if a participant is always available, an average of two messages are delivered per day.
The proximal treatment effect may vary across time for a variety of reasons. In HeartSteps, the treatment effect might initially increase, as it is believed that participants will enthusiastically engage with the intervention at the outset. Then, as the study goes on, some participants may disengage or begin to ignore the activity suggestions due to habituation, so we expect a decreasing proximal treatment effect. Thus, a plausible target alternative effect would be quadratic in time.
For example, we might be interested in the sample size needed to achieve at least 80% power when there is no initial treatment effect on the first day and the maximal proximal effect comes around day 28, or the amount of power we can guarantee with a sample size of 40. The results of sample sizes and power calculations for HeartSteps are provided in Figure 8 .
Conclusion
MRT-SS Calculator is designed to conduct sample size and power calculations for microrandomized trials, a new experimental framework which allows for the investigation of the effects of just-in-time mobile health interventions. Such interventions are of interest not only in the realm of physical activity, as in the example in Section 4, but also in the study of smoking cessation, obesity, congestive heart failure, and healthy eating, among others. MRT-SS Calculator is accessible, designed to elicit trial information from the scientist through a clear, well-explained sequence of inputs and provides real-time visual feedback. The calculator is also flexible, and capable of sizing trials which vary in complexity. MRT-SS Calculator can be used to quickly and reliably determine the minimal sample size needed to achieve a given power, or the power achievable given a sample size. MRT-SS Calculator can be used by scientists to ease the burden of designing micro-randomized trials to investigate proximal treatment effects.
A Simulation study
In this Appendix, we conduct a simulation study to investigate the power performance when sample size is 10 in settings where the theoretical power (with type I error rate α = 0.05) is above 0.8; or, equivalently, the required sample size to achieve 0.8 power is below 10. Such situations are likely to occur if: (a) The total number of decision times T is relatively large, due to either a large number of days or large number of decision times per day, (b) the provided average (standardized) proximal treatment effect is relatively large (say, 0.15), or the parameterization of the treatment effect is relatively simple, e.g. constant or linear, and (c) the average of expected availability throughout the study is relatively large. In the following, we provide simulation results for the above scenarios under different generative models.
First, we consider the case when the working assumptions made to obtain a tractable sample size calculation are satisfied; see Liao et al. (2016) for details. Since neither the working assumptions nor the inputs to the sample size formula specify the error distribution, we consider five distributions for the outcomes, including independent normal, correlated normal with different correlation structures, independent t-distribution with three degrees of freedom (heavy tailed) and independent (centered) exponential distribution with rate parameter equal to 1 (skewed). The simulation results are provided in Table A1 . In general, these results show that the power performance is still quite robust to different error distributions when the sample size equal to 10, as in the case of relatively large sample size demonstrated in Liao et al. (2016) .
Secondly, we consider the case in which the working assumptions proposed in Liao et al. (2016) are not satisfied. In particular, we consider two cases. In the first case, the timevarying pattern of underlying true proximal effects is different from the user-provided pattern. For example, the user might input a linear pattern for the treatment effect, but the true effects are quadratic. Instead the vector of standardized effect, d used in the sample size formula corresponds to the projection of d(t), that is, d = (
; see more details in Liao et al. (2016) . We consider three different patterns of treatment effect which cannot be represented as constant, linear and quadratic form, but can be sufficiently well approximated; see Figure A1 . Results are provided in Table A2 . As opposed to the case when sample size is relatively large, the simulated power results when N = 10 are slightly smaller than the power estimated by MRT-SS Calculator, roughly below 0.05.
In the second case, we investigate the performance when the conditional variance of the outcome at decision time t, e.g.
, is time-varying and depends on the treatment variable A t . It was reported in Liao et al. (2016) that when sample sizes are relatively large, power might decrease slightly depending on the choice of σ 0t and σ 1t . Here, we investigate whether robustness is maintained in small sample sizes (e.g. N = 10). We consider three time-varying trends for the average conditional variancē σ 2 t = ρσ 2 1t + (1 − ρ)σ 2 0t , together with different ratio of σ 1t and σ 0t ; see Figure A2 . The simulation results are given in Table A3 . It can be seen that the ratio factor σ 1t /σ 0t has almost no impact on the simulated power. Large variation inσ t , e.g. trend 3 in Figure  A2 , reduces the power in all cases. This is also true when sample size is relatively large: Table A1 : Simulation results when working assumptions are true. D = Number of Days. K = Number of decision times per day. Z refers to the parameterization of the treatment effect in both the sample size model and simulation: 0 = Constant, 1 = Linear, and 2 = Quadratic.d is the average standardized treatment effect. In all cases, the initial effect is 0, the treatment effects are identical within same day and the maximal effect is reached midway through the study. The underlying true effects in the generative model are the same as in the sample size model. The expected availability is assumed to be constant throughout the study and equal to 0.7. For the error distributions: the t distribution is used with 3 degrees of freedom; the rate parameter in the exponential distribution is 1; AR(ρ) and CSblock(ρ) are the correlated normal distributions with correlation structure Σ = (Σ
, and Σ ij = ρ for i = j in the same day, otherwise 0, respectively. Results are based on 1,000 replications. Table A2 : Simulation result when treatment effect is wrongly specified. D = Number of Days. K = Number of decision times per day. Z refers to the parameterization of the treatment effect in both sample size model and simulation; 0 = Constant, 1 = Linear, and 2 = Quadratic. β(t) is the underlying true treatment effect in the generative model; entries correspond to subfigures of Figure A1 .d is the average of standardized treatment effect. The expected availability is assumed to be constant throughout the study and equal to 0. Table A3 : Simulation result when the conditional variance of the outcome is time-varying and depends on the treatment variable. D = Number of Days. K = Number of decision times per day. Z refers to the parameterization of the treatment effect in both sample size model and simulation; 0 = Constant, 1 = Linear, and 2 = Quadratic.d is the average of standardized treatment effect. In all cases, the initial effect is 0, the treatment effects are identical within same day and attains the maximal effect midway through the study. The underlying true effects in the generative model are same as in the sample size model. The expected availability is assumed to be constant throughout the study and equal to 0.7. The ratio is defined as σ 1t /σ 0t and is assumed constant. The trend refers to three time-varying patterns of the average conditional variance {σ 
